Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT04115085
Other study ID # SUR
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date October 7, 2019
Est. completion date March 31, 2024

Study information

Verified date May 2023
Source Waldfriede Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

It was never investigated which preservative non-invasive treatments are superior to treat rhizarthrosis. This randomized study compares the effect of 1. hand therapy vs. 2. therapeutic ultrasound vs. 3. hand therapy plus therapeutic ultrasound in the treatment of rhizarthrosis.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 200
Est. completion date March 31, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 90 Years
Eligibility Inclusion Criteria: - Male and female patients aged 40 to 90 years - Pain intensity in the region of the thumb base in pain phases = 40 mm on the VAS of 0 to 100 mm (relative to the last 24 hours) - Complaints for at least 3 months - X-ray Stadium Eaton I-IV at least once secured Exclusion Criteria: - History of surgery on the affected hand, wrist or forearm - Planned surgery in the next 8 months - Anticoagulation (Marcumar, Heparin) - Haemophilia, V. Willebrandt Jürgens syndrome, thrombocytopathy and other blood anomalies - acute pain medication (<7 days) - Systemic medication with corticoids or immunosuppressants - Intraarterticular injections or RSO within the last 3 months - Pregnancy, lactation - Insulin-dependent type I diabetes mellitus - Significant cognitive impairment - clinically relevant or progressive disease (e.g., liver, kidney, cardiovascular system, respiratory tract, vascular system, brain, metabolism, thyroid) that could affect the course of the study - Malignant disease - Simultaneous participation in an interventional study or participation in an interventional study in the last two months before study inclusion - Clinically relevant addiction or substance abuse disorder (defined as alcohol, drug and drug abuse) - Insufficient mental possibility of cooperation - Therapy with oral anticoagulants (e.g., Marcumar) - Suspected lack of compliance - Medical, psychiatric or other conditions that restrict the patient's following abilities: to interpret the study information, to give informed consent, to adhere to the rules of the protocol, or to complete the study

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Hand therapy (18 treatments)
18 treatments (ea. 20 Min) within 9 weeks
Therapeutic ultrasound (18 treatments)
18 treatments (ea. 10 Min) within 9 weeks
Combined hand therapy and therapeutic ultrasound (18 treatments)
18 treatments (ea. 30 Min) within 9 weeks
Sham ultrasound group (18 treatments)
Sham ultrasound group receive 18 treatments (ea. 10 Min) within 9 weeks

Locations

Country Name City State
Germany Waldfriede Hospital Berlin

Sponsors (1)

Lead Sponsor Collaborator
Waldfriede Hospital

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Primary Disabilities of the Arm, Shoulder and Hand (DASH) Disabilities as measured by the DASH scale; No Difficulty (1), Mild Difficulty (2), Moderate Difficulty (3), Severe Difficulty (4), Unable (5) Change after 9 weeks and 3, 4 and 8 months
Secondary Visual analogue scale (VAS) pain From 0mm (no pain) to 100mm (maximum pain imaginable) Change after 9 weeks and 3, 4 and 8 months
Secondary Short Form 36 SF-36 Scored review of health questionnaire Change after 9 weeks and 3, 4 and 8 months
Secondary Functional assessment: Thumb force Key pinch force measure of the thumb as measured in Kg. Change after 9 weeks and 3, 4 and 8 months
Secondary Functional assessment: Goniometry Measurement of the angle between the dorsal axis of the thumb and the index finger with a goniometer. Change after 9 weeks and 3, 4 and 8 months
See also
  Status Clinical Trial Phase
Recruiting NCT04829565 - Assessment of Pain After Intra-articular Botulinum Toxin Injections in Carpometacarpal Osteoarthritis of the Thumb Phase 4
Recruiting NCT05047744 - Dual Mobility Total Joint Prosthesis (Touch) for Thumb Carpometacarpal Joint Osteoarthritis N/A
Recruiting NCT06078189 - Rhizarthrosis Surgery and Functional Recovery: Arthroplasty vs. Trapezectomy
Completed NCT03320291 - Long-term Evaluation of Primary Trapeziectomy and Placement of a RegJoint Implant in the Treatment of Rhizarthrosis N/A
Completed NCT04587570 - Rhizarthrosis Study N/A
Completed NCT02676284 - Durolane SJ for Treatment of Rhizarthrosis N/A
Recruiting NCT05597930 - New 3D Printed Wrist Orthosis N/A
Completed NCT03431584 - Effects on the Pain of an Infiltration by Acid Hyaluronic Association and Corticoids Versus Only Corticoids in the Rhizarthrosis. Phase 4
Active, not recruiting NCT03089723 - Saline Lavage X Saline Lavage and Osteonil® Mini in Rizarthritis N/A
Recruiting NCT01233739 - Chondroitin Sulphate Treatment Efficacy in Rhizarthrosis. Phase 4
Completed NCT05915962 - Biological Characterization Study of an Autograft Nanofat (Nanocarabio) N/A
Not yet recruiting NCT04588961 - Trapeziectomy Suspensionplasty Versus Carpometacarpal Joint Replacement in Treatment of Basal Thumb Osteoarthritis N/A
Terminated NCT03020368 - Effectiveness and Safety of Breeded Leech for Symptomatic Primary Arthrosis of the First Carpometacarpal Joint N/A
Completed NCT05169099 - Post-operative Results of the Trapezometacarpal (TMC) Prosthesis for Advanced Pre-operative Deformities
Recruiting NCT03879434 - Routine Application of Ostenil® Mini in Patients With Rhizarthrosis
Not yet recruiting NCT05708430 - Tolerance of Intra-articular Injection Autologous Stromal Vascular Fraction for the Treatment of Rhizarthrosis Phase 2